• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. 2016 U.S. Hepatitis Markers Testing Market: Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures - Research and Markets

    2016 U.S. Hepatitis Markers Testing Market: Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures - Research and Markets

  2. 2016 U.S. Enteric Disease Testing Market Analysis and Emerging Opportunities - Research and Markets

    2016 U.S. Enteric Disease Testing Market Analysis and Emerging Opportunities - Research and Markets

  3. United States Infectious Disease Testing Market 2016: Sales and Volume Segment Forecasts for 100 Tests - Research and Markets

    United States Infectious Disease Testing Market 2016: Sales and Volume Segment Forecasts for 100 Tests - Research and Markets

  4. Glaxosmithkline plc 4Q 2015 -- Forecast

    Glaxosmithkline plc 4Q 2015 -- Forecast

  5. 2016 U.S. POC/Point-of-Care Infectious Disease Testing Market Report - Research and Markets

    2016 U.S. POC/Point-of-Care Infectious Disease Testing Market Report - Research and Markets

  6. Apollo Therapeutics: Consortium of World-Leading UK Universities and Global Pharmaceutical Companies Launch £40 Million Fund to Drive Therapeutic Innovation

    Apollo Therapeutics: Consortium of World-Leading UK Universities and Global Pharmaceutical Companies Launch £40 Million Fund to Drive Therapeutic Innovation

  7. Technavio Announces Top Five Vendors in the Global Gastroesophageal Reflux Disease Drugs Market from 2016 to 2020

    Technavio Announces Top Five Vendors in the Global Gastroesophageal Reflux Disease Drugs Market from 2016 to 2020

  8. Common Questions (and Answers) for Uncommon Markets

    Five frequently asked questions for shell-shocked fund investors.

  9. 5 conspired to sell GlaxoSmithKline trade secrets, feds say

    5 conspired to sell GlaxoSmithKline trade secrets, feds say

  10. PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board

    PsiOxus Therapeutics Appoints Dr Paolo Paoletti as Chairman of the Board

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.